UMED logo

Unité de Fabrication des Médicaments S.A Stock Price

BVMT:UMED Community·د.ت290.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

UMED Share Price Performance

د.ت9.09
1.91 (26.60%)
د.ت9.09
1.91 (26.60%)
Price د.ت9.09

UMED Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

1 Risk
2 Rewards

Unité de Fabrication des Médicaments S.A Key Details

د.ت153.8m

Revenue

د.ت65.7m

Cost of Revenue

د.ت88.1m

Gross Profit

د.ت65.9m

Other Expenses

د.ت22.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.69
57.31%
14.45%
40.6%
View Full Analysis

About UMED

Founded
1989
Employees
n/a
CEO
Ridha Charfeddine
WebsiteView website
www.unimed.com.tn

Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic and fashioned medicines in Tunisia and internationally. The company offers ophthalmic, ENT, inhalation and infusion solutions, injectable fluids and penicillin, and cephalosporin powders for various therapeutic areas under the UNIMED brand name. It exports its products to Africa, Asia, and Europe. The company was founded in 1989 and is headquartered in Sousse, Tunisia.

Recent UMED News & Updates

Recent updates

No updates

Unité de Fabrication des Médicaments S.A Competitors